Schonfeld Strategic Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $616,641 - $994,909	50,503 New	50,503 $705,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $250,429 - $436,857	-22,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $960,821 - $1.28 Million	-71,864 Reduced 76.32%	22,300 $363,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $127,092 - $173,817	8,900 Added 10.44%	94,164 $1.53 Million
Q3 2021 Nov 16, 2021	BUY	$12.99 - $20.47 $956,245 - $1.51 Million	73,614 Added 631.88%	85,264 $1.27 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $180,109 - $285,425	11,650 New	11,650 $233,000
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $140,955 - $244,542	-5,758 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $427,527 - $584,473	-10,937 Reduced 65.51%	5,758 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $779,656 - $1.54 Million	16,695 New	16,695 $800,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $259,881 - $637,905	-5,375 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $1.54 Million - $3.33 Million	-26,825 Reduced 83.31%	5,375 $666,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $1.89 Million - $2.59 Million	32,200 New	32,200 $2.14 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $624,951 - $781,296	-10,738 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $612,173 - $1.28 Million	10,738	10,738 $623,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.